Novel motif:58
From FANTOM5_SSTAR
name: | motif58_CGGNAT |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:2000465 | regulation of glycogen (starch) synthase activity | 2.560208e-10 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 2.533555e-9 |
GO:0006414 | translational elongation | 4.321773e-9 |
GO:0016032 | viral reproduction | 6.308620e-9 |
GO:0006369 | termination of RNA polymerase II transcription | 1.487240e-8 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 1.728920e-8 |
GO:0014057 | positive regulation of acetylcholine secretion | 4.714360e-8 |
GO:0048143 | astrocyte activation | 4.979486e-8 |
GO:0050434 | positive regulation of viral transcription | 8.132806e-8 |
GO:0006353 | transcription termination, DNA-dependent | 1.439171e-7 |
GO:0046782 | regulation of viral transcription | 1.723801e-7 |
GO:0006415 | translational termination | 1.849412e-7 |
GO:0032790 | ribosome disassembly | 2.220130e-7 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 2.367296e-7 |
GO:0019083 | viral transcription | 5.402517e-7 |
GO:0044258 | intestinal lipid catabolic process | 7.775215e-7 |
GO:0018350 | protein esterification | 7.775215e-7 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 7.823945e-7 |
GO:0015820 | leucine transport | 8.526112e-7 |
GO:0035356 | cellular triglyceride homeostasis | 1.008223e-6 |
GO:0014056 | regulation of acetylcholine secretion | 1.757019e-6 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 1.865622e-6 |
GO:0006370 | mRNA capping | 3.088575e-6 |
GO:0009452 | RNA capping | 3.208213e-6 |
GO:0008033 | tRNA processing | 3.809284e-6 |
GO:0006102 | isocitrate metabolic process | 4.154322e-6 |
GO:0046626 | regulation of insulin receptor signaling pathway | 5.174270e-6 |
GO:0031017 | exocrine pancreas development | 5.386896e-6 |
GO:0007140 | male meiosis | 5.693234e-6 |
GO:0045725 | positive regulation of glycogen biosynthetic process | 5.839122e-6 |
GO:0006289 | nucleotide-excision repair | 6.038255e-6 |
GO:2000466 | negative regulation of glycogen (starch) synthase activity | 7.081697e-6 |
GO:0009650 | UV protection | 7.478181e-6 |
GO:0010626 | negative regulation of Schwann cell proliferation | 8.639595e-6 |
GO:0021591 | ventricular system development | 1.070165e-5 |
GO:0034633 | retinol transport | 1.295361e-5 |
GO:0030853 | negative regulation of granulocyte differentiation | 1.565864e-5 |
GO:0031064 | negative regulation of histone deacetylation | 1.658980e-5 |
GO:0046521 | sphingoid catabolic process | 1.691197e-5 |
GO:0051534 | negative regulation of NFAT protein import into nucleus | 1.730921e-5 |
GO:0048524 | positive regulation of viral reproduction | 1.784349e-5 |
GO:0006412 | translation | 1.821585e-5 |
GO:0048102 | autophagic cell death | 2.089188e-5 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 2.273361e-5 |
GO:0008588 | release of cytoplasmic sequestered NF-kappaB | 2.577305e-5 |
GO:0007141 | male meiosis I | 2.758859e-5 |
GO:0097151 | positive regulation of inhibitory postsynaptic membrane potential | 2.835060e-5 |
GO:0034623 | cellular macromolecular complex disassembly | 2.901680e-5 |
GO:0032984 | macromolecular complex disassembly | 2.997680e-5 |
GO:0031643 | positive regulation of myelination | 3.106154e-5 |
GO:0030823 | regulation of cGMP metabolic process | 3.192155e-5 |
GO:0016071 | mRNA metabolic process | 3.518600e-5 |
GO:0042946 | glucoside transport | 4.516616e-5 |
GO:0006396 | RNA processing | 4.965297e-5 |
GO:0030825 | positive regulation of cGMP metabolic process | 5.061599e-5 |
GO:0043624 | cellular protein complex disassembly | 5.173111e-5 |
GO:0010509 | polyamine homeostasis | 5.258169e-5 |
GO:0043241 | protein complex disassembly | 5.454029e-5 |
GO:0040040 | thermosensory behavior | 5.891931e-5 |
GO:0006103 | 2-oxoglutarate metabolic process | 6.325516e-5 |
GO:0034619 | cellular chaperone-mediated protein complex assembly | 6.496088e-5 |
GO:0021670 | lateral ventricle development | 6.547530e-5 |
GO:0000389 | nuclear mRNA 3'-splice site recognition | 6.576428e-5 |
GO:0070875 | positive regulation of glycogen metabolic process | 6.649022e-5 |
GO:0003417 | growth plate cartilage development | 7.047730e-5 |
GO:0006366 | transcription from RNA polymerase II promoter | 7.161073e-5 |
GO:0061360 | optic chiasma development | 7.634015e-5 |
GO:2000597 | positive regulation of optic nerve formation | 7.634015e-5 |
GO:0021650 | vestibulocochlear nerve formation | 7.634015e-5 |
GO:0021633 | optic nerve structural organization | 7.634015e-5 |
GO:0035799 | ureter maturation | 7.634015e-5 |
GO:0043486 | histone exchange | 7.638119e-5 |
GO:0046543 | development of secondary female sexual characteristics | 7.811716e-5 |
GO:0045136 | development of secondary sexual characteristics | 7.902127e-5 |
GO:0030237 | female sex determination | 7.922918e-5 |
GO:0035928 | rRNA import into mitochondrion | 8.299133e-5 |
GO:0003406 | retinal pigment epithelium development | 9.124586e-5 |
GO:0009062 | fatty acid catabolic process | 9.831125e-5 |
GO:0002072 | optic cup morphogenesis involved in camera-type eye development | 1.002544e-4 |
GO:0030213 | hyaluronan biosynthetic process | 1.020481e-4 |
GO:0033083 | regulation of immature T cell proliferation | 1.076975e-4 |
GO:0000080 | G1 phase of mitotic cell cycle | 1.184465e-4 |
GO:0019058 | viral infectious cycle | 1.240095e-4 |
GO:0021603 | cranial nerve formation | 1.256598e-4 |
GO:0000731 | DNA synthesis involved in DNA repair | 1.256598e-4 |
GO:0046395 | carboxylic acid catabolic process | 1.296995e-4 |
GO:0046778 | modification by virus of host mRNA processing | 1.297344e-4 |
GO:0009440 | cyanate catabolic process | 1.297344e-4 |
GO:0034470 | ncRNA processing | 1.319266e-4 |
GO:0072329 | monocarboxylic acid catabolic process | 1.329088e-4 |
GO:0032312 | regulation of ARF GTPase activity | 1.390406e-4 |
GO:0043585 | nose morphogenesis | 1.468022e-4 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 1.469247e-4 |
GO:0030157 | pancreatic juice secretion | 1.479860e-4 |
GO:0000375 | RNA splicing, via transesterification reactions | 1.494113e-4 |
GO:0032863 | activation of Rac GTPase activity | 1.552920e-4 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 1.578610e-4 |
GO:0032230 | positive regulation of synaptic transmission, GABAergic | 1.586679e-4 |
GO:0070253 | somatostatin secretion | 1.591463e-4 |
GO:0032812 | positive regulation of epinephrine secretion | 1.591463e-4 |
GO:0018293 | protein-FAD linkage | 1.646623e-4 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 1.646623e-4 |
GO:0032988 | ribonucleoprotein complex disassembly | 1.658595e-4 |
GO:0006383 | transcription from RNA polymerase III promoter | 1.736067e-4 |
GO:0035815 | positive regulation of renal sodium excretion | 1.822288e-4 |
GO:0005979 | regulation of glycogen biosynthetic process | 1.826284e-4 |
GO:0034080 | CenH3-containing nucleosome assembly at centromere | 1.840030e-4 |
GO:0019303 | D-ribose catabolic process | 2.006826e-4 |
GO:0043171 | peptide catabolic process | 2.153480e-4 |
GO:0043044 | ATP-dependent chromatin remodeling | 2.155910e-4 |
GO:0060253 | negative regulation of glial cell proliferation | 2.170092e-4 |
GO:0031914 | negative regulation of synaptic plasticity | 2.218940e-4 |
GO:0061054 | dermatome development | 2.301068e-4 |
GO:0030178 | negative regulation of Wnt receptor signaling pathway | 2.301513e-4 |
GO:0007288 | sperm axoneme assembly | 2.347550e-4 |
GO:0031018 | endocrine pancreas development | 2.447462e-4 |
GO:0006458 | 'de novo' protein folding | 2.476082e-4 |
GO:0050432 | catecholamine secretion | 2.594660e-4 |
GO:0060356 | leucine import | 2.732263e-4 |
GO:2000009 | negative regulation of protein localization at cell surface | 2.788525e-4 |
GO:0090031 | positive regulation of steroid hormone biosynthetic process | 2.957438e-4 |
GO:0009296 | flagellum assembly | 3.050274e-4 |
GO:0042762 | regulation of sulfur metabolic process | 3.062487e-4 |
GO:0003329 | pancreatic PP cell fate commitment | 3.074411e-4 |
GO:0003326 | pancreatic A cell fate commitment | 3.074411e-4 |
GO:0046514 | ceramide catabolic process | 3.094446e-4 |
GO:0000154 | rRNA modification | 3.159328e-4 |
GO:0034389 | lipid particle organization | 3.387175e-4 |
GO:0006930 | substrate-dependent cell migration, cell extension | 3.418246e-4 |
GO:0006398 | histone mRNA 3'-end processing | 3.597948e-4 |
GO:0051029 | rRNA transport | 3.712884e-4 |
GO:0034111 | negative regulation of homotypic cell-cell adhesion | 3.712884e-4 |
GO:0043381 | negative regulation of memory T cell differentiation | 3.773086e-4 |
GO:0043538 | regulation of actin phosphorylation | 3.773086e-4 |
GO:0006409 | tRNA export from nucleus | 3.895610e-4 |
GO:0010954 | positive regulation of protein processing | 4.163545e-4 |
GO:0035621 | ER to Golgi ceramide transport | 4.234481e-4 |
GO:0072553 | terminal button organization | 4.234481e-4 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 4.244477e-4 |
GO:0051176 | positive regulation of sulfur metabolic process | 4.351064e-4 |
GO:0045040 | protein import into mitochondrial outer membrane | 4.440934e-4 |
GO:0032228 | regulation of synaptic transmission, GABAergic | 4.547167e-4 |
GO:0001886 | endothelial cell morphogenesis | 4.581503e-4 |
GO:0042797 | tRNA transcription from RNA polymerase III promoter | 4.978954e-4 |
GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter | 4.978954e-4 |
GO:0035090 | maintenance of apical/basal cell polarity | 4.992308e-4 |
GO:0015853 | adenine transport | 5.310581e-4 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 5.391027e-4 |
GO:0045199 | maintenance of epithelial cell apical/basal polarity | 5.671407e-4 |
GO:0030208 | dermatan sulfate biosynthetic process | 5.671407e-4 |
GO:0006772 | thiamine metabolic process | 5.884144e-4 |
GO:0035411 | catenin import into nucleus | 6.115041e-4 |
GO:0032855 | positive regulation of Rac GTPase activity | 6.126914e-4 |
GO:0030852 | regulation of granulocyte differentiation | 6.162972e-4 |
GO:0090103 | cochlea morphogenesis | 6.289009e-4 |
GO:0061037 | negative regulation of cartilage development | 6.344606e-4 |
GO:0002679 | respiratory burst involved in defense response | 6.352834e-4 |
GO:0015886 | heme transport | 6.352834e-4 |
GO:2000119 | negative regulation of sodium-dependent phosphate transport | 6.404675e-4 |
GO:0014819 | regulation of skeletal muscle contraction | 6.515245e-4 |
GO:0007023 | post-chaperonin tubulin folding pathway | 6.515245e-4 |
GO:0072300 | positive regulation of metanephric glomerulus development | 6.702148e-4 |
GO:0071897 | DNA biosynthetic process | 6.825963e-4 |
GO:0031558 | induction of apoptosis in response to chemical stimulus | 6.871621e-4 |
GO:0006399 | tRNA metabolic process | 7.468683e-4 |
GO:0006635 | fatty acid beta-oxidation | 7.539795e-4 |
GO:0042218 | 1-aminocyclopropane-1-carboxylate biosynthetic process | 7.595230e-4 |
GO:0042254 | ribosome biogenesis | 7.706104e-4 |
GO:0006097 | glyoxylate cycle | 7.851461e-4 |
GO:0009301 | snRNA transcription | 7.930164e-4 |
GO:0021932 | hindbrain radial glia guided cell migration | 8.278973e-4 |
GO:0032674 | regulation of interleukin-5 production | 8.398535e-4 |
GO:0045655 | regulation of monocyte differentiation | 8.554140e-4 |
GO:0031055 | chromatin remodeling at centromere | 8.578218e-4 |
GO:0033260 | DNA replication involved in S phase | 8.630683e-4 |
GO:0042450 | arginine biosynthetic process via ornithine | 8.630683e-4 |
GO:0031118 | rRNA pseudouridine synthesis | 8.630683e-4 |
GO:0008049 | male courtship behavior | 8.630683e-4 |
GO:0010734 | negative regulation of protein glutathionylation | 8.630683e-4 |
GO:0021933 | radial glia guided migration of cerebellar granule cell | 8.630683e-4 |
GO:0001957 | intramembranous ossification | 8.834371e-4 |
GO:0021562 | vestibulocochlear nerve development | 8.882302e-4 |
GO:0090090 | negative regulation of canonical Wnt receptor signaling pathway | 9.170239e-4 |
GO:0070873 | regulation of glycogen metabolic process | 9.424392e-4 |
GO:0021559 | trigeminal nerve development | 9.632101e-4 |
GO:0021526 | medial motor column neuron differentiation | 1.016294e-3 |
GO:0010756 | positive regulation of plasminogen activation | 1.062215e-3 |
GO:0043089 | positive regulation of Cdc42 GTPase activity | 1.076181e-3 |
GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein | 1.083626e-3 |
GO:0001970 | positive regulation of activation of membrane attack complex | 1.091126e-3 |
GO:0009304 | tRNA transcription | 1.098588e-3 |
GO:0043491 | protein kinase B signaling cascade | 1.123290e-3 |
GO:0014044 | Schwann cell development | 1.154633e-3 |
GO:0051084 | 'de novo' posttranslational protein folding | 1.157539e-3 |
GO:0002121 | inter-male aggressive behavior | 1.162987e-3 |
GO:0048069 | eye pigmentation | 1.165699e-3 |
GO:0014020 | primary neural tube formation | 1.173391e-3 |
GO:0006457 | protein folding | 1.174708e-3 |
GO:0043064 | flagellum organization | 1.183395e-3 |
GO:0034498 | early endosome to Golgi transport | 1.184524e-3 |
GO:0048313 | Golgi inheritance | 1.184524e-3 |
GO:0006612 | protein targeting to membrane | 1.184765e-3 |
GO:0032754 | positive regulation of interleukin-5 production | 1.243159e-3 |
GO:0002149 | hypochlorous acid biosynthetic process | 1.255896e-3 |
GO:0032714 | negative regulation of interleukin-5 production | 1.296513e-3 |
GO:0002074 | extraocular skeletal muscle development | 1.317312e-3 |
GO:0034259 | negative regulation of Rho GTPase activity | 1.317312e-3 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.317312e-3 |
GO:0072162 | metanephric mesenchymal cell differentiation | 1.318864e-3 |
GO:0045345 | positive regulation of MHC class I biosynthetic process | 1.326948e-3 |
GO:0016264 | gap junction assembly | 1.420839e-3 |
GO:0042703 | menstruation | 1.471683e-3 |
GO:0019101 | female somatic sex determination | 1.471683e-3 |
GO:0042375 | quinone cofactor metabolic process | 1.492657e-3 |
GO:0044240 | multicellular organismal lipid catabolic process | 1.495073e-3 |
GO:0051457 | maintenance of protein location in nucleus | 1.512755e-3 |
GO:0006349 | regulation of gene expression by genetic imprinting | 1.545177e-3 |
GO:0060707 | trophoblast giant cell differentiation | 1.574721e-3 |
GO:0051318 | G1 phase | 1.585760e-3 |
GO:0060816 | random inactivation of X chromosome | 1.676216e-3 |
GO:0050666 | regulation of homocysteine metabolic process | 1.679276e-3 |
GO:0016140 | O-glycoside metabolic process | 1.679276e-3 |
GO:0042723 | thiamine-containing compound metabolic process | 1.752526e-3 |
GO:0031662 | positive regulation of cyclin-dependent protein kinase activity involved in G2/M | 1.758095e-3 |
GO:0070194 | synaptonemal complex disassembly | 1.758095e-3 |
GO:0019448 | L-cysteine catabolic process | 1.758095e-3 |
GO:0006707 | cholesterol catabolic process | 1.762582e-3 |
GO:0001843 | neural tube closure | 1.784283e-3 |
GO:0009060 | aerobic respiration | 1.785091e-3 |
GO:0016142 | O-glycoside catabolic process | 1.799237e-3 |
GO:0006308 | DNA catabolic process | 1.832278e-3 |
GO:0044282 | small molecule catabolic process | 1.865351e-3 |
GO:0043921 | modulation by host of viral transcription | 1.876813e-3 |
GO:0040020 | regulation of meiosis | 1.886436e-3 |
GO:0035566 | regulation of metanephros size | 1.958247e-3 |
GO:0001778 | plasma membrane repair | 2.036233e-3 |
GO:0019556 | histidine catabolic process to glutamate and formamide | 2.036271e-3 |
GO:0008272 | sulfate transport | 2.154871e-3 |
GO:0021592 | fourth ventricle development | 2.183800e-3 |
GO:0003309 | type B pancreatic cell differentiation | 2.212420e-3 |
GO:0043114 | regulation of vascular permeability | 2.215894e-3 |
GO:0007006 | mitochondrial membrane organization | 2.227961e-3 |
GO:0031016 | pancreas development | 2.269540e-3 |
GO:0051567 | histone H3-K9 methylation | 2.280833e-3 |
GO:0043088 | regulation of Cdc42 GTPase activity | 2.287745e-3 |
GO:0003416 | endochondral bone growth | 2.301751e-3 |
GO:0021523 | somatic motor neuron differentiation | 2.316051e-3 |
GO:0090150 | establishment of protein localization in membrane | 2.316051e-3 |
GO:0045963 | negative regulation of dopamine metabolic process | 2.342858e-3 |
GO:0050668 | positive regulation of homocysteine metabolic process | 2.342858e-3 |
GO:0035445 | borate transmembrane transport | 2.342858e-3 |
GO:0009401 | phosphoenolpyruvate-dependent sugar phosphotransferase system | 2.342858e-3 |
GO:0072595 | maintenance of protein localization to organelle | 2.350850e-3 |
GO:0042363 | fat-soluble vitamin catabolic process | 2.355590e-3 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | 2.377242e-3 |
GO:0001963 | synaptic transmission, dopaminergic | 2.378349e-3 |
GO:0010070 | zygote asymmetric cell division | 2.392971e-3 |
GO:0009451 | RNA modification | 2.411344e-3 |
GO:0060349 | bone morphogenesis | 2.419544e-3 |
GO:0006432 | phenylalanyl-tRNA aminoacylation | 2.444060e-3 |
GO:0001956 | positive regulation of neurotransmitter secretion | 2.518563e-3 |
GO:0001514 | selenocysteine incorporation | 2.518563e-3 |
GO:0045749 | negative regulation of S phase of mitotic cell cycle | 2.524726e-3 |
GO:0071930 | negative regulation of transcription involved in G1/S phase of mitotic cell cycle | 2.533825e-3 |
GO:0030322 | stabilization of membrane potential | 2.548308e-3 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 2.591994e-3 |
GO:0060606 | tube closure | 2.603732e-3 |
GO:0018993 | somatic sex determination | 2.686704e-3 |
GO:0010890 | positive regulation of sequestering of triglyceride | 2.686704e-3 |
GO:0001757 | somite specification | 2.732237e-3 |
GO:0071899 | negative regulation of estrogen receptor binding | 2.743616e-3 |
GO:0072201 | negative regulation of mesenchymal cell proliferation | 2.822989e-3 |
GO:0006235 | dTTP biosynthetic process | 3.175026e-3 |
GO:0000088 | mitotic prophase | 3.175026e-3 |
GO:0006281 | DNA repair | 3.187843e-3 |
GO:0048708 | astrocyte differentiation | 3.248429e-3 |
GO:0030091 | protein repair | 3.308602e-3 |
GO:0060708 | spongiotrophoblast differentiation | 3.313400e-3 |
GO:0021943 | formation of radial glial scaffolds | 3.342953e-3 |
GO:0070245 | positive regulation of thymocyte apoptosis | 3.350424e-3 |
GO:0002066 | columnar/cuboidal epithelial cell development | 3.471363e-3 |
GO:0006364 | rRNA processing | 3.542117e-3 |
GO:0051131 | chaperone-mediated protein complex assembly | 3.604451e-3 |
GO:0006354 | transcription elongation, DNA-dependent | 3.605593e-3 |
GO:0042373 | vitamin K metabolic process | 3.620853e-3 |
GO:0002069 | columnar/cuboidal epithelial cell maturation | 3.620853e-3 |
GO:2000273 | positive regulation of receptor activity | 3.637647e-3 |
GO:0043973 | histone H3-K4 acetylation | 3.666939e-3 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 3.666939e-3 |
GO:0043418 | homocysteine catabolic process | 3.666939e-3 |
GO:0006535 | cysteine biosynthetic process from serine | 3.666939e-3 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 3.666939e-3 |
GO:0019343 | cysteine biosynthetic process via cystathionine | 3.666939e-3 |
GO:0019346 | transsulfuration | 3.666939e-3 |
GO:0051965 | positive regulation of synapse assembly | 3.798162e-3 |
GO:0032288 | myelin assembly | 3.804657e-3 |
GO:0000012 | single strand break repair | 3.814695e-3 |
GO:0034959 | endothelin maturation | 3.818105e-3 |
GO:0010814 | substance P catabolic process | 3.818105e-3 |
GO:0010816 | calcitonin catabolic process | 3.818105e-3 |
GO:0010815 | bradykinin catabolic process | 3.848444e-3 |
GO:0016226 | iron-sulfur cluster assembly | 3.880309e-3 |
GO:0016048 | detection of temperature stimulus | 3.981468e-3 |
GO:0021535 | cell migration in hindbrain | 3.992981e-3 |
GO:0060056 | mammary gland involution | 4.039194e-3 |
GO:0045063 | T-helper 1 cell differentiation | 4.047163e-3 |
GO:0070831 | basement membrane assembly | 4.055689e-3 |
GO:0035646 | endosome to melanosome transport | 4.055689e-3 |
GO:0030683 | evasion by virus of host immune response | 4.055689e-3 |
GO:0045606 | positive regulation of epidermal cell differentiation | 4.222365e-3 |
GO:0071514 | genetic imprinting | 4.239023e-3 |
GO:0034660 | ncRNA metabolic process | 4.289876e-3 |
GO:0045343 | regulation of MHC class I biosynthetic process | 4.329382e-3 |
GO:0051445 | regulation of meiotic cell cycle | 4.450819e-3 |
GO:0010821 | regulation of mitochondrion organization | 4.463430e-3 |
GO:0046380 | N-acetylneuraminate biosynthetic process | 4.470944e-3 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 4.470944e-3 |
GO:0016078 | tRNA catabolic process | 4.470944e-3 |
GO:0001682 | tRNA 5'-leader removal | 4.470944e-3 |
GO:0072668 | tubulin complex biogenesis | 4.484489e-3 |
GO:0055026 | negative regulation of cardiac muscle tissue development | 4.537521e-3 |
GO:0043570 | maintenance of DNA repeat elements | 4.598789e-3 |
GO:0033091 | positive regulation of immature T cell proliferation | 4.598789e-3 |
GO:0060689 | cell differentiation involved in salivary gland development | 4.709692e-3 |
GO:0001510 | RNA methylation | 4.789286e-3 |
GO:0033088 | negative regulation of immature T cell proliferation in thymus | 4.798655e-3 |
GO:0045409 | negative regulation of interleukin-6 biosynthetic process | 4.841376e-3 |
GO:2000077 | negative regulation of type B pancreatic cell development | 4.879112e-3 |
GO:0006422 | aspartyl-tRNA aminoacylation | 4.963485e-3 |
GO:0007339 | binding of sperm to zona pellucida | 4.980596e-3 |
GO:0007007 | inner mitochondrial membrane organization | 5.121094e-3 |
GO:0032107 | regulation of response to nutrient levels | 5.122115e-3 |
GO:0061384 | heart trabecular morphogenesis | 5.170921e-3 |
GO:0035922 | foramen ovale closure | 5.204853e-3 |
GO:0060577 | pulmonary vein morphogenesis | 5.204853e-3 |
GO:0003193 | pulmonary valve formation | 5.204853e-3 |
GO:0000354 | cis assembly of pre-catalytic spliceosome | 5.204853e-3 |
GO:0048703 | embryonic viscerocranium morphogenesis | 5.376634e-3 |
GO:0051187 | cofactor catabolic process | 5.439778e-3 |
GO:0008065 | establishment of blood-nerve barrier | 5.490247e-3 |
GO:0002071 | glandular epithelial cell maturation | 5.490247e-3 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 5.496343e-3 |
GO:0045657 | positive regulation of monocyte differentiation | 5.526952e-3 |
GO:0021678 | third ventricle development | 5.631856e-3 |
GO:0045719 | negative regulation of glycogen biosynthetic process | 5.673295e-3 |
GO:0032656 | regulation of interleukin-13 production | 5.795642e-3 |
GO:0003344 | pericardium morphogenesis | 5.858073e-3 |
GO:0032696 | negative regulation of interleukin-13 production | 5.863814e-3 |
GO:0043923 | positive regulation by host of viral transcription | 5.922590e-3 |
GO:0007263 | nitric oxide mediated signal transduction | 6.026236e-3 |
GO:0060347 | heart trabecula formation | 6.029557e-3 |
GO:0051881 | regulation of mitochondrial membrane potential | 6.109305e-3 |
GO:0052312 | modulation of transcription in other organism involved in symbiotic interaction | 6.209422e-3 |
GO:0048103 | somatic stem cell division | 6.239644e-3 |
GO:0048821 | erythrocyte development | 6.280878e-3 |
GO:0032736 | positive regulation of interleukin-13 production | 6.291002e-3 |
GO:0060157 | urinary bladder development | 6.393375e-3 |
GO:0035567 | non-canonical Wnt receptor signaling pathway | 6.410188e-3 |
GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation | 6.483082e-3 |
GO:0060580 | ventral spinal cord interneuron fate determination | 6.551789e-3 |
GO:0003327 | type B pancreatic cell fate commitment | 6.551789e-3 |
GO:0033484 | nitric oxide homeostasis | 6.668423e-3 |
GO:0019054 | modulation by virus of host cellular process | 6.754329e-3 |
GO:0006863 | purine base transport | 6.754329e-3 |
GO:0090193 | positive regulation of glomerulus development | 6.842156e-3 |
GO:0030223 | neutrophil differentiation | 6.882081e-3 |
GO:0034214 | protein hexamerization | 6.994868e-3 |
GO:0016072 | rRNA metabolic process | 7.050388e-3 |
GO:0090037 | positive regulation of protein kinase C signaling cascade | 7.057282e-3 |
GO:0019395 | fatty acid oxidation | 7.112773e-3 |
GO:0045200 | establishment of neuroblast polarity | 7.184079e-3 |
GO:0070368 | positive regulation of hepatocyte differentiation | 7.184079e-3 |
GO:0003310 | pancreatic A cell differentiation | 7.405260e-3 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 7.484408e-3 |
GO:0042989 | sequestering of actin monomers | 7.510934e-3 |
GO:0006488 | dolichol-linked oligosaccharide biosynthetic process | 7.693570e-3 |
GO:2000035 | regulation of stem cell division | 7.915410e-3 |
GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair | 8.000538e-3 |
GO:0021589 | cerebellum structural organization | 8.043661e-3 |
GO:0060904 | regulation of protein folding in endoplasmic reticulum | 8.043661e-3 |
GO:0035024 | negative regulation of Rho protein signal transduction | 8.087168e-3 |
GO:0060340 | positive regulation of type I interferon-mediated signaling pathway | 8.292905e-3 |
GO:0032717 | negative regulation of interleukin-8 production | 8.292905e-3 |
GO:0045658 | regulation of neutrophil differentiation | 8.428686e-3 |
GO:0009450 | gamma-aminobutyric acid catabolic process | 8.446790e-3 |
GO:0071425 | hemopoietic stem cell proliferation | 8.474720e-3 |
GO:0090002 | establishment of protein localization in plasma membrane | 8.596594e-3 |
GO:0070366 | regulation of hepatocyte differentiation | 8.631198e-3 |
GO:0000028 | ribosomal small subunit assembly | 8.771554e-3 |
GO:0007223 | Wnt receptor signaling pathway, calcium modulating pathway | 8.857425e-3 |
GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin | 8.867773e-3 |
GO:0051001 | negative regulation of nitric-oxide synthase activity | 8.908914e-3 |
GO:0046426 | negative regulation of JAK-STAT cascade | 8.917518e-3 |
GO:0032095 | regulation of response to food | 9.026306e-3 |
GO:0009109 | coenzyme catabolic process | 9.060382e-3 |
GO:0003100 | regulation of systemic arterial blood pressure by endothelin | 9.164069e-3 |
GO:0042538 | hyperosmotic salinity response | 9.168109e-3 |
GO:0044089 | positive regulation of cellular component biogenesis | 9.256021e-3 |
GO:0031063 | regulation of histone deacetylation | 9.256021e-3 |
GO:0043400 | cortisol secretion | 9.281445e-3 |
GO:0031275 | regulation of lateral pseudopodium assembly | 9.281445e-3 |
GO:0002572 | pro-T cell differentiation | 9.281445e-3 |
GO:0043922 | negative regulation by host of viral transcription | 9.282362e-3 |
GO:0010520 | regulation of reciprocal meiotic recombination | 9.484096e-3 |
GO:0043308 | eosinophil degranulation | 9.697473e-3 |
GO:0017196 | N-terminal peptidyl-methionine acetylation | 9.697473e-3 |
GO:0007341 | penetration of zona pellucida | 9.846153e-3 |
GO:0018198 | peptidyl-cysteine modification | 9.874392e-3 |
GO:0032801 | receptor catabolic process | 9.911046e-3 |
GO:0060026 | convergent extension | 9.917935e-3 |
GO:0003065 | positive regulation of heart rate by epinephrine | 9.978304e-3 |
GO:0044062 | regulation of excretion | 9.992815e-3 |
GO:0002528 | regulation of vascular permeability involved in acute inflammatory response | 1.019925e-2 |
GO:0018023 | peptidyl-lysine trimethylation | 1.021658e-2 |
GO:0060744 | mammary gland branching involved in thelarche | 1.024395e-2 |
GO:0070234 | positive regulation of T cell apoptosis | 1.031763e-2 |
GO:0046621 | negative regulation of organ growth | 1.031763e-2 |
GO:0021506 | anterior neuropore closure | 1.042728e-2 |
GO:0014916 | regulation of lung blood pressure | 1.042728e-2 |
GO:0000266 | mitochondrial fission | 1.055072e-2 |
GO:0003062 | regulation of heart rate by chemical signal | 1.067130e-2 |
GO:0015780 | nucleotide-sugar transport | 1.072130e-2 |
GO:0071335 | hair follicle cell proliferation | 1.104622e-2 |
GO:0032290 | peripheral nervous system myelin formation | 1.104622e-2 |
GO:0019323 | pentose catabolic process | 1.104622e-2 |
GO:0051594 | detection of glucose | 1.106559e-2 |
GO:0010909 | positive regulation of heparan sulfate proteoglycan biosynthetic process | 1.114820e-2 |
GO:0044334 | canonical Wnt receptor signaling pathway involved in positive regulation of epithelial to mesenchymal transition | 1.114820e-2 |
GO:0000239 | pachytene | 1.116043e-2 |
GO:0060376 | positive regulation of mast cell differentiation | 1.117437e-2 |
GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process | 1.117437e-2 |
GO:0032469 | endoplasmic reticulum calcium ion homeostasis | 1.127732e-2 |
GO:0015696 | ammonium transport | 1.140920e-2 |
GO:0007127 | meiosis I | 1.149902e-2 |
GO:0090344 | negative regulation of cell aging | 1.159831e-2 |
GO:0006397 | mRNA processing | 1.177440e-2 |
GO:0048861 | leukemia inhibitory factor signaling pathway | 1.181275e-2 |
GO:0060299 | negative regulation of sarcomere organization | 1.184420e-2 |
GO:0033292 | T-tubule organization | 1.184420e-2 |
GO:0046491 | L-methylmalonyl-CoA metabolic process | 1.184420e-2 |
GO:0030851 | granulocyte differentiation | 1.188948e-2 |
GO:0032235 | negative regulation of calcium ion transport via store-operated calcium channel activity | 1.194075e-2 |
GO:0016559 | peroxisome fission | 1.194075e-2 |
GO:0014028 | notochord formation | 1.194075e-2 |
GO:0003184 | pulmonary valve morphogenesis | 1.194075e-2 |
GO:0070544 | histone H3-K36 demethylation | 1.200566e-2 |
GO:0022011 | myelination in peripheral nervous system | 1.201225e-2 |
GO:0003148 | outflow tract septum morphogenesis | 1.224328e-2 |
GO:0060041 | retina development in camera-type eye | 1.226092e-2 |
GO:0090140 | regulation of mitochondrial fission | 1.226200e-2 |
GO:0031167 | rRNA methylation | 1.226200e-2 |
GO:0060711 | labyrinthine layer development | 1.231267e-2 |
GO:0006261 | DNA-dependent DNA replication | 1.232816e-2 |
GO:0035813 | regulation of renal sodium excretion | 1.267282e-2 |
GO:0031557 | induction of programmed cell death in response to chemical stimulus | 1.272906e-2 |
GO:0042104 | positive regulation of activated T cell proliferation | 1.273710e-2 |
GO:0003323 | type B pancreatic cell development | 1.282063e-2 |
GO:0021623 | oculomotor nerve formation | 1.299943e-2 |
GO:0003409 | optic cup structural organization | 1.299943e-2 |
GO:0003404 | optic vesicle morphogenesis | 1.299943e-2 |
GO:0031134 | sister chromatid biorientation | 1.304120e-2 |
GO:0006423 | cysteinyl-tRNA aminoacylation | 1.304120e-2 |
GO:0035036 | sperm-egg recognition | 1.309895e-2 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 1.326024e-2 |
GO:0071895 | odontoblast differentiation | 1.345242e-2 |
GO:0003188 | heart valve formation | 1.351142e-2 |
GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase | 1.358213e-2 |
GO:0034440 | lipid oxidation | 1.384545e-2 |
GO:0032926 | negative regulation of activin receptor signaling pathway | 1.413143e-2 |
GO:0048242 | epinephrine secretion | 1.423867e-2 |
GO:0016973 | poly(A)+ mRNA export from nucleus | 1.425876e-2 |
GO:0007340 | acrosome reaction | 1.435916e-2 |
GO:0035112 | genitalia morphogenesis | 1.439753e-2 |
GO:0006534 | cysteine metabolic process | 1.441663e-2 |
GO:0002829 | negative regulation of type 2 immune response | 1.441663e-2 |
GO:0006914 | autophagy | 1.456094e-2 |
GO:0043631 | RNA polyadenylation | 1.473872e-2 |
GO:0035082 | axoneme assembly | 1.492400e-2 |
GO:0006548 | histidine catabolic process | 1.494760e-2 |
GO:0010845 | positive regulation of reciprocal meiotic recombination | 1.498436e-2 |
GO:0035883 | enteroendocrine cell differentiation | 1.498436e-2 |
GO:0060611 | mammary gland fat development | 1.503545e-2 |
GO:0007020 | microtubule nucleation | 1.510852e-2 |
GO:0034110 | regulation of homotypic cell-cell adhesion | 1.525845e-2 |
GO:0045836 | positive regulation of meiosis | 1.545872e-2 |
GO:0010907 | positive regulation of glucose metabolic process | 1.567010e-2 |
GO:0035121 | tail morphogenesis | 1.585703e-2 |
GO:0090244 | Wnt receptor signaling pathway involved in somitogenesis | 1.585860e-2 |
GO:0051593 | response to folic acid | 1.595326e-2 |
GO:0016446 | somatic hypermutation of immunoglobulin genes | 1.606378e-2 |
GO:0006378 | mRNA polyadenylation | 1.611844e-2 |
GO:0045947 | negative regulation of translational initiation | 1.635085e-2 |
GO:0048793 | pronephros development | 1.637015e-2 |
GO:0015709 | thiosulfate transport | 1.652662e-2 |
GO:0071423 | malate transmembrane transport | 1.652662e-2 |
GO:0048291 | isotype switching to IgG isotypes | 1.652662e-2 |
GO:0010760 | negative regulation of macrophage chemotaxis | 1.652662e-2 |
GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 1.652662e-2 |
GO:0002368 | B cell cytokine production | 1.652662e-2 |
GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 1.653442e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0031577 | spindle checkpoint | 7.100880e-9 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 2.347315e-8 |
GO:0007099 | centriole replication | 2.691364e-8 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 1.750573e-7 |
GO:0006397 | mRNA processing | 2.162021e-7 |
GO:0071173 | spindle assembly checkpoint | 2.490136e-7 |
GO:0033344 | cholesterol efflux | 2.816096e-7 |
GO:0051298 | centrosome duplication | 3.700037e-7 |
GO:0034442 | regulation of lipoprotein oxidation | 3.761026e-7 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 5.182475e-7 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 5.470243e-7 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 1.200662e-6 |
GO:0008380 | RNA splicing | 1.324337e-6 |
GO:0006260 | DNA replication | 1.392148e-6 |
GO:0033239 | negative regulation of cellular amine metabolic process | 1.404418e-6 |
GO:2000078 | positive regulation of type B pancreatic cell development | 1.831104e-6 |
GO:0035928 | rRNA import into mitochondrion | 1.831104e-6 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 2.236555e-6 |
GO:0032374 | regulation of cholesterol transport | 3.640968e-6 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 6.752776e-6 |
GO:0060307 | regulation of ventricular cardiomyocyte membrane repolarization | 9.832160e-6 |
GO:0060299 | negative regulation of sarcomere organization | 9.832160e-6 |
GO:0043691 | reverse cholesterol transport | 1.079953e-5 |
GO:0033700 | phospholipid efflux | 1.079953e-5 |
GO:0034447 | very-low-density lipoprotein particle clearance | 1.783147e-5 |
GO:0000279 | M phase | 1.789297e-5 |
GO:0043457 | regulation of cellular respiration | 1.844125e-5 |
GO:0090244 | Wnt receptor signaling pathway involved in somitogenesis | 1.982710e-5 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 2.002573e-5 |
GO:0006396 | RNA processing | 2.130126e-5 |
GO:0061181 | regulation of chondrocyte development | 2.151427e-5 |
GO:0032048 | cardiolipin metabolic process | 2.158678e-5 |
GO:0042697 | menopause | 2.963307e-5 |
GO:0071827 | plasma lipoprotein particle organization | 3.779367e-5 |
GO:0006476 | protein deacetylation | 3.961542e-5 |
GO:0007141 | male meiosis I | 4.245871e-5 |
GO:0042254 | ribosome biogenesis | 5.227668e-5 |
GO:0006982 | response to lipid hydroperoxide | 5.559580e-5 |
GO:0045647 | negative regulation of erythrocyte differentiation | 5.833147e-5 |
GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity | 5.847458e-5 |
GO:0060217 | hemangioblast cell differentiation | 5.847458e-5 |
GO:0045799 | positive regulation of chromatin assembly or disassembly | 5.847458e-5 |
GO:0022417 | protein maturation by protein folding | 5.847458e-5 |
GO:0090343 | positive regulation of cell aging | 6.712054e-5 |
GO:0032368 | regulation of lipid transport | 7.286967e-5 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 7.504010e-5 |
GO:0035601 | protein deacylation | 7.915329e-5 |
GO:0051004 | regulation of lipoprotein lipase activity | 8.588391e-5 |
GO:0000305 | response to oxygen radical | 8.681979e-5 |
GO:0032049 | cardiolipin biosynthetic process | 9.125741e-5 |
GO:0031397 | negative regulation of protein ubiquitination | 9.363643e-5 |
GO:0046958 | nonassociative learning | 9.372165e-5 |
GO:0006302 | double-strand break repair | 9.814183e-5 |
GO:0045919 | positive regulation of cytolysis | 1.123465e-4 |
GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway | 1.123465e-4 |
GO:0040040 | thermosensory behavior | 1.123465e-4 |
GO:0007067 | mitosis | 1.144547e-4 |
GO:0022403 | cell cycle phase | 1.207438e-4 |
GO:0072560 | type B pancreatic cell maturation | 1.324701e-4 |
GO:0033037 | polysaccharide localization | 1.357915e-4 |
GO:0050746 | regulation of lipoprotein metabolic process | 1.385428e-4 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 1.395515e-4 |
GO:0000087 | M phase of mitotic cell cycle | 1.493093e-4 |
GO:0061084 | negative regulation of protein refolding | 1.559279e-4 |
GO:0048285 | organelle fission | 1.609310e-4 |
GO:0055090 | acylglycerol homeostasis | 1.645052e-4 |
GO:0034369 | plasma lipoprotein particle remodeling | 1.708401e-4 |
GO:0007127 | meiosis I | 1.753323e-4 |
GO:0001579 | medium-chain fatty acid transport | 2.070683e-4 |
GO:0042157 | lipoprotein metabolic process | 2.091662e-4 |
GO:0019430 | removal of superoxide radicals | 2.113066e-4 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 2.131289e-4 |
GO:0070172 | positive regulation of tooth mineralization | 2.182061e-4 |
GO:0015920 | lipopolysaccharide transport | 2.196708e-4 |
GO:0090398 | cellular senescence | 2.210900e-4 |
GO:0060136 | embryonic process involved in female pregnancy | 2.309419e-4 |
GO:0007144 | female meiosis I | 2.380232e-4 |
GO:0060696 | regulation of phospholipid catabolic process | 2.453270e-4 |
GO:0046984 | regulation of hemoglobin biosynthetic process | 2.499301e-4 |
GO:0006235 | dTTP biosynthetic process | 2.697936e-4 |
GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase | 2.697936e-4 |
GO:2000774 | positive regulation of cellular senescence | 3.038363e-4 |
GO:0090402 | oncogene-induced senescence | 3.038363e-4 |
GO:0035986 | senescence-associated heterochromatin focus formation | 3.038363e-4 |
GO:0007093 | mitotic cell cycle checkpoint | 3.175042e-4 |
GO:0006403 | RNA localization | 3.471088e-4 |
GO:0032532 | regulation of microvillus length | 3.488032e-4 |
GO:0060005 | vestibular reflex | 3.493065e-4 |
GO:0000303 | response to superoxide | 3.860243e-4 |
GO:0031334 | positive regulation of protein complex assembly | 3.862936e-4 |
GO:0006805 | xenobiotic metabolic process | 3.884051e-4 |
GO:0071711 | basement membrane organization | 3.921759e-4 |
GO:0006611 | protein export from nucleus | 3.981131e-4 |
GO:0097006 | regulation of plasma lipoprotein particle levels | 4.262929e-4 |
GO:0031507 | heterochromatin formation | 4.649294e-4 |
GO:0050684 | regulation of mRNA processing | 4.694866e-4 |
GO:0007098 | centrosome cycle | 4.697507e-4 |
GO:0060993 | kidney morphogenesis | 4.933822e-4 |
GO:0001935 | endothelial cell proliferation | 4.966010e-4 |
GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis | 4.978738e-4 |
GO:0046314 | phosphocreatine biosynthetic process | 5.033153e-4 |
GO:0051865 | protein autoubiquitination | 5.070217e-4 |
GO:0043243 | positive regulation of protein complex disassembly | 5.411768e-4 |
GO:0018009 | N-terminal peptidyl-L-cysteine N-palmitoylation | 5.439857e-4 |
GO:0043570 | maintenance of DNA repeat elements | 5.557299e-4 |
GO:0051725 | protein de-ADP-ribosylation | 5.656402e-4 |
GO:0043254 | regulation of protein complex assembly | 5.793126e-4 |
GO:0090161 | Golgi ribbon formation | 5.835010e-4 |
GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity | 5.835010e-4 |
GO:0070602 | regulation of centromeric sister chromatid cohesion | 5.914937e-4 |
GO:0032530 | regulation of microvillus organization | 6.108237e-4 |
GO:0033211 | adiponectin-mediated signaling pathway | 6.152172e-4 |
GO:0006913 | nucleocytoplasmic transport | 6.179724e-4 |
GO:0051276 | chromosome organization | 6.192041e-4 |
GO:0003065 | positive regulation of heart rate by epinephrine | 6.197548e-4 |
GO:0046902 | regulation of mitochondrial membrane permeability | 6.666768e-4 |
GO:0046092 | deoxycytidine metabolic process | 6.854770e-4 |
GO:0060534 | trachea cartilage development | 6.936868e-4 |
GO:0033238 | regulation of cellular amine metabolic process | 6.960971e-4 |
GO:0031116 | positive regulation of microtubule polymerization | 7.056531e-4 |
GO:0016071 | mRNA metabolic process | 7.139441e-4 |
GO:0006281 | DNA repair | 7.372853e-4 |
GO:0000083 | regulation of transcription involved in G1/S phase of mitotic cell cycle | 7.444416e-4 |
GO:0046605 | regulation of centrosome cycle | 7.723057e-4 |
GO:0032271 | regulation of protein polymerization | 7.847886e-4 |
GO:0007129 | synapsis | 8.657930e-4 |
GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway | 8.779121e-4 |
GO:0046853 | inositol or phosphatidylinositol phosphorylation | 8.779121e-4 |
GO:0032226 | positive regulation of synaptic transmission, dopaminergic | 8.779121e-4 |
GO:0071316 | cellular response to nicotine | 9.784361e-4 |
GO:0002227 | innate immune response in mucosa | 9.859373e-4 |
GO:0032423 | regulation of mismatch repair | 1.015055e-3 |
GO:0060669 | embryonic placenta morphogenesis | 1.050037e-3 |
GO:0035414 | negative regulation of catenin import into nucleus | 1.058164e-3 |
GO:0061156 | pulmonary artery morphogenesis | 1.066485e-3 |
GO:0051956 | negative regulation of amino acid transport | 1.066485e-3 |
GO:0031536 | positive regulation of exit from mitosis | 1.066485e-3 |
GO:0045837 | negative regulation of membrane potential | 1.071005e-3 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 1.072958e-3 |
GO:0032383 | regulation of intracellular cholesterol transport | 1.072958e-3 |
GO:0015939 | pantothenate metabolic process | 1.072958e-3 |
GO:0018065 | protein-cofactor linkage | 1.085440e-3 |
GO:0051169 | nuclear transport | 1.104086e-3 |
GO:0048793 | pronephros development | 1.120347e-3 |
GO:0000432 | positive regulation of transcription from RNA polymerase II promoter by glucose | 1.144247e-3 |
GO:0042743 | hydrogen peroxide metabolic process | 1.197965e-3 |
GO:0051299 | centrosome separation | 1.224343e-3 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.224343e-3 |
GO:0007063 | regulation of sister chromatid cohesion | 1.228894e-3 |
GO:0009082 | branched chain family amino acid biosynthetic process | 1.271566e-3 |
GO:0000185 | activation of MAPKKK activity | 1.271566e-3 |
GO:0000070 | mitotic sister chromatid segregation | 1.379628e-3 |
GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 1.404048e-3 |
GO:0070192 | chromosome organization involved in meiosis | 1.425988e-3 |
GO:0060364 | frontal suture morphogenesis | 1.438286e-3 |
GO:0043973 | histone H3-K4 acetylation | 1.446702e-3 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 1.446702e-3 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 1.446702e-3 |
GO:0018101 | peptidyl-citrulline biosynthetic process from peptidyl-arginine | 1.446702e-3 |
GO:0042178 | xenobiotic catabolic process | 1.501533e-3 |
GO:0019255 | glucose 1-phosphate metabolic process | 1.530528e-3 |
GO:0019218 | regulation of steroid metabolic process | 1.558881e-3 |
GO:0045839 | negative regulation of mitosis | 1.607763e-3 |
GO:0051438 | regulation of ubiquitin-protein ligase activity | 1.640937e-3 |
GO:0030970 | retrograde protein transport, ER to cytosol | 1.654792e-3 |
GO:0051798 | positive regulation of hair follicle development | 1.683077e-3 |
GO:0018345 | protein palmitoylation | 1.704808e-3 |
GO:0033088 | negative regulation of immature T cell proliferation in thymus | 1.714472e-3 |
GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 1.714472e-3 |
GO:0065005 | protein-lipid complex assembly | 1.722556e-3 |
GO:2000053 | regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 1.733666e-3 |
GO:0072422 | signal transduction involved in DNA damage checkpoint | 1.741491e-3 |
GO:0048298 | positive regulation of isotype switching to IgA isotypes | 1.826232e-3 |
GO:0051340 | regulation of ligase activity | 1.894442e-3 |
GO:0090200 | positive regulation of release of cytochrome c from mitochondria | 1.906638e-3 |
GO:0046890 | regulation of lipid biosynthetic process | 1.929962e-3 |
GO:0051983 | regulation of chromosome segregation | 1.944059e-3 |
GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine | 1.946604e-3 |
GO:0043922 | negative regulation by host of viral transcription | 1.969074e-3 |
GO:0071624 | positive regulation of granulocyte chemotaxis | 2.003050e-3 |
GO:0000085 | G2 phase of mitotic cell cycle | 2.018826e-3 |
GO:0050658 | RNA transport | 2.030542e-3 |
GO:0043523 | regulation of neuron apoptosis | 2.035018e-3 |
GO:0031113 | regulation of microtubule polymerization | 2.078392e-3 |
GO:0016032 | viral reproduction | 2.105309e-3 |
GO:0090312 | positive regulation of protein deacetylation | 2.126838e-3 |
GO:0071843 | cellular component biogenesis at cellular level | 2.211193e-3 |
GO:0018394 | peptidyl-lysine acetylation | 2.238910e-3 |
GO:0000819 | sister chromatid segregation | 2.250975e-3 |
GO:0042769 | DNA damage response, detection of DNA damage | 2.287320e-3 |
GO:0035855 | megakaryocyte development | 2.293460e-3 |
GO:0007346 | regulation of mitotic cell cycle | 2.304943e-3 |
GO:0032897 | negative regulation of viral transcription | 2.352151e-3 |
GO:0035802 | adrenal cortex formation | 2.353426e-3 |
GO:0072194 | kidney smooth muscle tissue development | 2.353426e-3 |
GO:0010948 | negative regulation of cell cycle process | 2.402244e-3 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 2.405212e-3 |
GO:0018393 | internal peptidyl-lysine acetylation | 2.480540e-3 |
GO:0051444 | negative regulation of ubiquitin-protein ligase activity | 2.501218e-3 |
GO:0018293 | protein-FAD linkage | 2.516108e-3 |
GO:0042228 | interleukin-8 biosynthetic process | 2.516108e-3 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 2.516108e-3 |
GO:0000379 | tRNA-type intron splice site recognition and cleavage | 2.516108e-3 |
GO:0071158 | positive regulation of cell cycle arrest | 2.614394e-3 |
GO:0018106 | peptidyl-histidine phosphorylation | 2.624079e-3 |
GO:0032508 | DNA duplex unwinding | 2.811341e-3 |
GO:0022402 | cell cycle process | 2.830407e-3 |
GO:0045940 | positive regulation of steroid metabolic process | 2.855806e-3 |
GO:0042304 | regulation of fatty acid biosynthetic process | 2.870817e-3 |
GO:0070925 | organelle assembly | 2.923250e-3 |
GO:0010467 | gene expression | 2.942747e-3 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 3.000285e-3 |
GO:0060535 | trachea cartilage morphogenesis | 3.018542e-3 |
GO:0001970 | positive regulation of activation of membrane attack complex | 3.018542e-3 |
GO:0031396 | regulation of protein ubiquitination | 3.037499e-3 |
GO:0043244 | regulation of protein complex disassembly | 3.070021e-3 |
GO:0033572 | transferrin transport | 3.070737e-3 |
GO:0071279 | cellular response to cobalt ion | 3.108172e-3 |
GO:0035356 | cellular triglyceride homeostasis | 3.108172e-3 |
GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 3.108172e-3 |
GO:0010637 | negative regulation of mitochondrial fusion | 3.108172e-3 |
GO:0032077 | positive regulation of deoxyribonuclease activity | 3.108172e-3 |
GO:0032277 | negative regulation of gonadotropin secretion | 3.172033e-3 |
GO:0010898 | positive regulation of triglyceride catabolic process | 3.188591e-3 |
GO:0072180 | mesonephric duct morphogenesis | 3.278643e-3 |
GO:0051915 | induction of synaptic plasticity by chemical substance | 3.306542e-3 |
GO:0010824 | regulation of centrosome duplication | 3.306542e-3 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 3.308581e-3 |
GO:0007168 | receptor guanylyl cyclase signaling pathway | 3.380407e-3 |
GO:0072098 | anterior/posterior pattern specification involved in kidney development | 3.384005e-3 |
GO:0048389 | intermediate mesoderm development | 3.384005e-3 |
GO:0002036 | regulation of L-glutamate transport | 3.384005e-3 |
GO:0006172 | ADP biosynthetic process | 3.384005e-3 |
GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity | 3.494656e-3 |
GO:0006438 | valyl-tRNA aminoacylation | 3.494656e-3 |
GO:0043543 | protein acylation | 3.545914e-3 |
GO:0033108 | mitochondrial respiratory chain complex assembly | 3.595167e-3 |
GO:0006974 | response to DNA damage stimulus | 3.605464e-3 |
GO:0030432 | peristalsis | 3.684535e-3 |
GO:0051029 | rRNA transport | 3.762914e-3 |
GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 3.842078e-3 |
GO:0032392 | DNA geometric change | 3.872776e-3 |
GO:0006606 | protein import into nucleus | 3.972965e-3 |
GO:0071156 | regulation of cell cycle arrest | 3.995739e-3 |
GO:0050689 | negative regulation of defense response to virus by host | 4.029210e-3 |
GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis | 4.061351e-3 |
GO:0070669 | response to interleukin-2 | 4.204157e-3 |
GO:0071281 | cellular response to iron ion | 4.204157e-3 |
GO:2001038 | regulation of cellular response to drug | 4.204157e-3 |
GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining | 4.204157e-3 |
GO:2000685 | positive regulation of cellular response to X-ray | 4.204157e-3 |
GO:0035978 | histone H2A-S139 phosphorylation | 4.204157e-3 |
GO:0001306 | age-dependent response to oxidative stress | 4.204157e-3 |
GO:0035988 | chondrocyte proliferation | 4.204157e-3 |
GO:0003131 | mesodermal-endodermal cell signaling | 4.204157e-3 |
GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process | 4.204157e-3 |
GO:0031052 | chromosome breakage | 4.204157e-3 |
GO:0051795 | positive regulation of catagen | 4.298002e-3 |
GO:0061162 | establishment of monopolar cell polarity | 4.314086e-3 |
GO:0003062 | regulation of heart rate by chemical signal | 4.439223e-3 |
GO:0007049 | cell cycle | 4.444906e-3 |
GO:0072331 | signal transduction by p53 class mediator | 4.532978e-3 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 4.565721e-3 |
GO:0015696 | ammonium transport | 4.586638e-3 |
GO:2000772 | regulation of cellular senescence | 4.595275e-3 |
GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter | 4.693873e-3 |
GO:0072361 | regulation of glycolysis by regulation of transcription from RNA polymerase II promoter | 4.693873e-3 |
GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter | 4.776268e-3 |
GO:0072362 | regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter | 4.776268e-3 |
GO:0061307 | cardiac neural crest cell differentiation involved in heart development | 4.872126e-3 |
GO:0071930 | negative regulation of transcription involved in G1/S phase of mitotic cell cycle | 4.875425e-3 |
GO:0003349 | epicardium-derived cardiac endothelial cell differentiation | 4.875425e-3 |
GO:0060084 | synaptic transmission involved in micturition | 4.981261e-3 |
GO:0034259 | negative regulation of Rho GTPase activity | 4.981261e-3 |
GO:0010918 | positive regulation of mitochondrial membrane potential | 4.981261e-3 |
GO:0045994 | positive regulation of translational initiation by iron | 4.987741e-3 |
GO:0061048 | negative regulation of branching involved in lung morphogenesis | 4.987741e-3 |
GO:0034116 | positive regulation of heterotypic cell-cell adhesion | 4.987741e-3 |
GO:0018242 | protein O-linked glycosylation via serine | 4.987741e-3 |
GO:0030221 | basophil differentiation | 4.987741e-3 |
GO:0002037 | negative regulation of L-glutamate transport | 4.987741e-3 |
GO:0018243 | protein O-linked glycosylation via threonine | 4.987741e-3 |
GO:0002385 | mucosal immune response | 4.999065e-3 |
GO:0017148 | negative regulation of translation | 5.098478e-3 |
GO:0060363 | cranial suture morphogenesis | 5.192309e-3 |
GO:0035404 | histone-serine phosphorylation | 5.198387e-3 |
GO:0051044 | positive regulation of membrane protein ectodomain proteolysis | 5.249160e-3 |
GO:0045136 | development of secondary sexual characteristics | 5.262063e-3 |
GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint | 5.311542e-3 |
GO:0018916 | nitrobenzene metabolic process | 5.311542e-3 |
GO:0071352 | cellular response to interleukin-2 | 5.311542e-3 |
GO:0006497 | protein lipidation | 5.331264e-3 |
GO:0032367 | intracellular cholesterol transport | 5.332065e-3 |
GO:0033002 | muscle cell proliferation | 5.375519e-3 |
GO:0048818 | positive regulation of hair follicle maturation | 5.406037e-3 |
GO:0002149 | hypochlorous acid biosynthetic process | 5.406037e-3 |
GO:0060123 | regulation of growth hormone secretion | 5.424222e-3 |
GO:0031662 | positive regulation of cyclin-dependent protein kinase activity involved in G2/M | 5.486407e-3 |
GO:0072268 | pattern specification involved in metanephros development | 5.486407e-3 |
GO:0051170 | nuclear import | 5.553844e-3 |
GO:0042771 | DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis | 5.581501e-3 |
GO:0072178 | nephric duct morphogenesis | 5.658985e-3 |
GO:0000724 | double-strand break repair via homologous recombination | 5.713901e-3 |
GO:0002328 | pro-B cell differentiation | 5.756009e-3 |
GO:0046543 | development of secondary female sexual characteristics | 5.917542e-3 |
GO:0048240 | sperm capacitation | 5.983617e-3 |
GO:0006984 | ER-nucleus signaling pathway | 6.075974e-3 |
GO:2000275 | regulation of oxidative phosphorylation uncoupler activity | 6.093999e-3 |
GO:0034227 | tRNA thio-modification | 6.093999e-3 |
GO:0016358 | dendrite development | 6.165911e-3 |
GO:0072088 | nephron epithelium morphogenesis | 6.169818e-3 |
GO:0007253 | cytoplasmic sequestering of NF-kappaB | 6.197023e-3 |
GO:0034384 | high-density lipoprotein particle clearance | 6.206206e-3 |
GO:0051135 | positive regulation of NK T cell activation | 6.265471e-3 |
GO:0051321 | meiotic cell cycle | 6.276243e-3 |
GO:0006475 | internal protein amino acid acetylation | 6.371092e-3 |
GO:0007080 | mitotic metaphase plate congression | 6.398421e-3 |
GO:0021675 | nerve development | 6.402640e-3 |
GO:0043526 | neuroprotection | 6.410156e-3 |
GO:0009410 | response to xenobiotic stimulus | 6.456372e-3 |
GO:0010822 | positive regulation of mitochondrion organization | 6.552164e-3 |
GO:0032057 | negative regulation of translational initiation in response to stress | 6.564815e-3 |
GO:0008611 | ether lipid biosynthetic process | 6.564815e-3 |
GO:0031129 | inductive cell-cell signaling | 6.564815e-3 |
GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus | 6.644401e-3 |
GO:0046599 | regulation of centriole replication | 6.730979e-3 |
GO:0000052 | citrulline metabolic process | 6.730979e-3 |
GO:0006353 | transcription termination, DNA-dependent | 6.730979e-3 |
GO:0000075 | cell cycle checkpoint | 6.863324e-3 |
GO:0051006 | positive regulation of lipoprotein lipase activity | 6.955257e-3 |
GO:0019240 | citrulline biosynthetic process | 7.038787e-3 |
GO:0046931 | pore complex assembly | 7.057752e-3 |
GO:0000738 | DNA catabolic process, exonucleolytic | 7.110926e-3 |
GO:0031112 | positive regulation of microtubule polymerization or depolymerization | 7.204984e-3 |
GO:0021545 | cranial nerve development | 7.228179e-3 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 7.302274e-3 |
GO:0000733 | DNA strand renaturation | 7.360649e-3 |
GO:0022613 | ribonucleoprotein complex biogenesis | 7.423814e-3 |
GO:0001969 | regulation of activation of membrane attack complex | 7.555866e-3 |
GO:0010872 | regulation of cholesterol esterification | 7.648212e-3 |
GO:2000172 | regulation of branching morphogenesis of a nerve | 7.783085e-3 |
GO:0042347 | negative regulation of NF-kappaB import into nucleus | 7.790375e-3 |
GO:0072332 | signal transduction by p53 class mediator resulting in induction of apoptosis | 7.950339e-3 |
GO:0035095 | behavioral response to nicotine | 7.964286e-3 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 7.964286e-3 |
GO:0006139 | nucleobase-containing compound metabolic process | 7.977825e-3 |
GO:0042744 | hydrogen peroxide catabolic process | 7.984220e-3 |
GO:0002251 | organ or tissue specific immune response | 8.087414e-3 |
GO:0070328 | triglyceride homeostasis | 8.197566e-3 |
GO:0007262 | STAT protein import into nucleus | 8.293542e-3 |
GO:0030301 | cholesterol transport | 8.400576e-3 |
GO:0007076 | mitotic chromosome condensation | 8.552008e-3 |
GO:0045069 | regulation of viral genome replication | 8.617160e-3 |
GO:0070997 | neuron death | 8.619886e-3 |
GO:0032516 | positive regulation of phosphoprotein phosphatase activity | 8.835802e-3 |
GO:2000384 | negative regulation of ectoderm development | 8.866289e-3 |
GO:0006268 | DNA unwinding involved in replication | 8.918346e-3 |
GO:0046015 | regulation of transcription by glucose | 8.927418e-3 |
GO:0090185 | negative regulation of kidney development | 8.959055e-3 |
GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine | 9.021747e-3 |
GO:0044260 | cellular macromolecule metabolic process | 9.065203e-3 |
GO:0051881 | regulation of mitochondrial membrane potential | 9.065946e-3 |
GO:0016573 | histone acetylation | 9.179602e-3 |
GO:0051402 | neuron apoptosis | 9.238638e-3 |
GO:0010984 | regulation of lipoprotein particle clearance | 9.287537e-3 |
GO:0006658 | phosphatidylserine metabolic process | 9.532512e-3 |
GO:0031065 | positive regulation of histone deacetylation | 9.627840e-3 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 9.666476e-3 |
GO:0000725 | recombinational repair | 9.743374e-3 |
GO:0008542 | visual learning | 9.748748e-3 |
GO:0072177 | mesonephric duct development | 9.825198e-3 |
GO:0008306 | associative learning | 9.842069e-3 |
GO:0042982 | amyloid precursor protein metabolic process | 9.994157e-3 |
GO:0070831 | basement membrane assembly | 1.008397e-2 |
GO:0038027 | apolipoprotein A-I-mediated signaling pathway | 1.008397e-2 |
GO:0008636 | activation of caspase activity by protein phosphorylation | 1.008397e-2 |
GO:0035409 | histone H3-Y41 phosphorylation | 1.008397e-2 |
GO:0072205 | metanephric collecting duct development | 1.008704e-2 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 1.009589e-2 |
GO:0010939 | regulation of necrotic cell death | 1.011086e-2 |
GO:2000054 | negative regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 1.014416e-2 |
GO:0048148 | behavioral response to cocaine | 1.014416e-2 |
GO:0051382 | kinetochore assembly | 1.018340e-2 |
GO:0071460 | cellular response to cell-matrix adhesion | 1.018340e-2 |
GO:0045329 | carnitine biosynthetic process | 1.018340e-2 |
GO:0003409 | optic cup structural organization | 1.024631e-2 |
GO:0021623 | oculomotor nerve formation | 1.024631e-2 |
GO:0003404 | optic vesicle morphogenesis | 1.024631e-2 |
GO:0006446 | regulation of translational initiation | 1.024924e-2 |
GO:0006818 | hydrogen transport | 1.028113e-2 |
GO:0071044 | histone mRNA catabolic process | 1.030667e-2 |
GO:0007260 | tyrosine phosphorylation of STAT protein | 1.055363e-2 |
GO:0006493 | protein O-linked glycosylation | 1.060249e-2 |
GO:0072176 | nephric duct development | 1.072677e-2 |
GO:0018205 | peptidyl-lysine modification | 1.091345e-2 |
GO:0015969 | guanosine tetraphosphate metabolic process | 1.096299e-2 |
GO:0007285 | primary spermatocyte growth | 1.096299e-2 |
GO:0006256 | UDP catabolic process | 1.096299e-2 |
GO:0060125 | negative regulation of growth hormone secretion | 1.107202e-2 |
GO:0071217 | cellular response to external biotic stimulus | 1.107202e-2 |
GO:0061015 | snRNA import into nucleus | 1.107202e-2 |
GO:0051463 | negative regulation of cortisol secretion | 1.107202e-2 |
GO:0007057 | spindle assembly involved in female meiosis I | 1.107202e-2 |
GO:0021771 | lateral geniculate nucleus development | 1.107202e-2 |
GO:0035502 | metanephric ureteric bud development | 1.107202e-2 |
GO:0006702 | androgen biosynthetic process | 1.121918e-2 |
GO:0045738 | negative regulation of DNA repair | 1.123253e-2 |
GO:0071816 | tail-anchored membrane protein insertion into ER membrane | 1.123253e-2 |
GO:0060018 | astrocyte fate commitment | 1.129681e-2 |
GO:0015986 | ATP synthesis coupled proton transport | 1.131394e-2 |
GO:0019048 | virus-host interaction | 1.149740e-2 |
GO:0018198 | peptidyl-cysteine modification | 1.165059e-2 |
GO:0060555 | induction of necroptosis by extracellular signals | 1.189282e-2 |
GO:0061312 | BMP signaling pathway involved in heart development | 1.189282e-2 |
GO:0045654 | positive regulation of megakaryocyte differentiation | 1.189282e-2 |
GO:0032497 | detection of lipopolysaccharide | 1.189282e-2 |
GO:0048630 | skeletal muscle tissue growth | 1.196593e-2 |
GO:0072593 | reactive oxygen species metabolic process | 1.205438e-2 |
GO:0006364 | rRNA processing | 1.216031e-2 |
GO:0044065 | regulation of respiratory system process | 1.218701e-2 |
GO:0008635 | activation of caspase activity by cytochrome c | 1.236650e-2 |
GO:0007064 | mitotic sister chromatid cohesion | 1.245653e-2 |
GO:0031440 | regulation of mRNA 3'-end processing | 1.245653e-2 |
GO:0060218 | hemopoietic stem cell differentiation | 1.248280e-2 |
GO:0045869 | negative regulation of retroviral genome replication | 1.251287e-2 |
GO:0034088 | maintenance of mitotic sister chromatid cohesion | 1.251287e-2 |
GO:0090342 | regulation of cell aging | 1.284811e-2 |
GO:0009437 | carnitine metabolic process | 1.293894e-2 |
GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus | 1.295811e-2 |
GO:0032202 | telomere assembly | 1.295811e-2 |
GO:0003130 | BMP signaling pathway involved in heart induction | 1.295811e-2 |
GO:0032981 | mitochondrial respiratory chain complex I assembly | 1.340050e-2 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 1.340050e-2 |
GO:0007618 | mating | 1.346356e-2 |
GO:0043484 | regulation of RNA splicing | 1.365835e-2 |
GO:0008629 | induction of apoptosis by intracellular signals | 1.373298e-2 |
GO:0060670 | branching involved in embryonic placenta morphogenesis | 1.390493e-2 |
GO:0007091 | mitotic metaphase/anaphase transition | 1.392116e-2 |
GO:0001672 | regulation of chromatin assembly or disassembly | 1.392116e-2 |
GO:0019098 | reproductive behavior | 1.398604e-2 |
GO:0042758 | long-chain fatty acid catabolic process | 1.412473e-2 |
GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport | 1.412473e-2 |
GO:0042413 | carnitine catabolic process | 1.412473e-2 |
GO:0010501 | RNA secondary structure unwinding | 1.412473e-2 |
GO:0006498 | N-terminal protein lipidation | 1.412473e-2 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 1.416471e-2 |
GO:0031627 | telomeric loop formation | 1.416579e-2 |
GO:0000237 | leptotene | 1.416579e-2 |
GO:0071577 | zinc ion transmembrane transport | 1.438948e-2 |
GO:0035261 | external genitalia morphogenesis | 1.448753e-2 |
GO:0072161 | mesenchymal cell differentiation involved in kidney development | 1.452328e-2 |
GO:0021557 | oculomotor nerve development | 1.452328e-2 |
GO:0071385 | cellular response to glucocorticoid stimulus | 1.456542e-2 |
GO:0072210 | metanephric nephron development | 1.457787e-2 |
GO:0030837 | negative regulation of actin filament polymerization | 1.470187e-2 |
GO:0007096 | regulation of exit from mitosis | 1.474408e-2 |
GO:0061046 | regulation of branching involved in lung morphogenesis | 1.474408e-2 |
GO:0035912 | dorsal aorta morphogenesis | 1.475946e-2 |
GO:0030038 | contractile actin filament bundle assembly | 1.475946e-2 |
GO:0009107 | lipoate biosynthetic process | 1.475946e-2 |
GO:0008216 | spermidine metabolic process | 1.475946e-2 |
GO:2000018 | regulation of male gonad development | 1.476452e-2 |
GO:0007220 | Notch receptor processing | 1.476452e-2 |
GO:0051563 | smooth endoplasmic reticulum calcium ion homeostasis | 1.484063e-2 |
GO:0051693 | actin filament capping | 1.488494e-2 |
GO:0060557 | positive regulation of vitamin D biosynthetic process | 1.493441e-2 |
GO:0090304 | nucleic acid metabolic process | 1.510878e-2 |
GO:0010498 | proteasomal protein catabolic process | 1.524709e-2 |
GO:0072028 | nephron morphogenesis | 1.550938e-2 |
GO:0000278 | mitotic cell cycle | 1.560497e-2 |
GO:0006417 | regulation of translation | 1.583420e-2 |
GO:2000020 | positive regulation of male gonad development | 1.591276e-2 |
GO:0035176 | social behavior | 1.598226e-2 |
GO:0015992 | proton transport | 1.606025e-2 |
GO:0016575 | histone deacetylation | 1.610681e-2 |
GO:0017038 | protein import | 1.623758e-2 |
GO:0050925 | negative regulation of negative chemotaxis | 1.625637e-2 |
GO:0051443 | positive regulation of ubiquitin-protein ligase activity | 1.637305e-2 |
GO:0050881 | musculoskeletal movement | 1.640454e-2 |
GO:0000381 | regulation of alternative nuclear mRNA splicing, via spliceosome | 1.652771e-2 |
GO:0048024 | regulation of nuclear mRNA splicing, via spliceosome | 1.654573e-2 |
GO:0006829 | zinc ion transport | 1.668240e-2 |
GO:0032490 | detection of molecule of bacterial origin | 1.678670e-2 |
GO:0021554 | optic nerve development | 1.681218e-2 |
GO:0033554 | cellular response to stress | 1.684630e-2 |
GO:0006473 | protein acetylation | 1.690717e-2 |
GO:0060564 | negative regulation of mitotic anaphase-promoting complex activity | 1.699946e-2 |
GO:0010724 | regulation of definitive erythrocyte differentiation | 1.706803e-2 |
GO:0006284 | base-excision repair | 1.714449e-2 |
GO:0071071 | regulation of phospholipid biosynthetic process | 1.727025e-2 |
GO:0052312 | modulation of transcription in other organism involved in symbiotic interaction | 1.733827e-2 |
GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine | 1.739727e-2 |
GO:0070584 | mitochondrion morphogenesis | 1.752574e-2 |
GO:0007569 | cell aging | 1.767814e-2 |
GO:0001662 | behavioral fear response | 1.776421e-2 |
GO:0045922 | negative regulation of fatty acid metabolic process | 1.776960e-2 |
GO:0030834 | regulation of actin filament depolymerization | 1.779072e-2 |
GO:0032375 | negative regulation of cholesterol transport | 1.794138e-2 |
GO:0071549 | cellular response to dexamethasone stimulus | 1.816871e-2 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 1.823250e-2 |